Merck & Co Inc
Nine of the largest pharma companies ink deals with Trump to lower drug prices
President Donald Trump signs an executive order aimed at reducing the cost of prescription drugs and pharmaceuticals by 30% to 80% during an event in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images Several of the largest U.S. and European-based drugmakers inked deals with […]
Read More
FDA approves Merck drug for decimated U.S. cattle herds to stop screwworm
Cattle detained in the pens of the Chihuahua Regional Livestock Union , at the Jeronimo-Santa Teresa border crossing in Ciudad Juarez, Mexico on November 27, 2024, after the United States stopped imports of Mexican cattle due to the presence of screwworm. Anadolu | Anadolu | Getty Images U.S. cattle ranchers will soon have a new […]
Read More
Stocks making the biggest moves midday: Novo Nordisk, Inspire Medical, Tesla, Tegna, Oscar Health and more
Check out the companies making the biggest moves midday: Novo Nordisk — The Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Shares tumbled nearly 6%. Inspire Medical Systems — The maker of an obstructive sleep apnea treatment will benefit from Friday’s decision by the Centers […]
Read More
Stocks making the biggest moves premarket: Novo Nordisk, Tesla, Alphabet, Oscar Health & more
Check out the companies making the biggest moves in premarket trading: Novo Nordisk — Shares tumbled 10% after the Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Tesla — CEO Elon Musk said on X that the company is close to finalizing its latest artificial-intelligence […]
Read More
We don’t have high hopes for this tech stock, but we’re thrilled with this bank
Two portfolio stocks are making news Monday — one in enterprise software and the other in banking. Earnings preview : Bank of America lowered its price target on Salesforce to $305 per share from $325 ahead of quarterly earnings next month. The analysts, who kept a buy rating on shares, cited cheaper multiples across software peers, […]
Read More
Stocks making the biggest premarket moves: Warner Bros. Discovery, Cidara Therapeutics, Avadel Pharmaceuticals and more
Check out the companies making headlines before the bell. Cidara Therapeutics — Shares of Cidara surged 103% after Merck agreed to buy the company for close to $9.2 billion in cash. Merck fell 1%. Avadel Pharmaceuticals — Danish drugmaker Lundbeck offered to acquire the pharmaceutical company for as much as $23 per share, topping biotech […]
Read More
Merck bets on flu prevention with about $9.2 billion deal for Cidara Therapeutics
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention. Merck is looking to diversify its revenue beyond Keytruda […]
Read More
We’re raising our Eli Lilly price target — what a difference a quarter makes
Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year […]
Read More
Stocks making the biggest moves premarket: Alphabet, Microsoft, Meta Platforms, Eli Lilly, Merck & more
Check out the companies making headlines before the bell: Alphabet — The search giant jumped more than 7% after strong results that were boosted by revenue from Google Cloud and YouTube advertising. Alphabet earned $3.10 per share, on an adjusted basis, more than the $2.33 per share expected by analysts polled by LSEG. Revenue of […]
Read More
Merck tops estimates on Keytruda strength and narrows profit outlook, as it lowers estimated tariff hit
Merck on Thursday reported third-quarter earnings and revenue that topped estimates as it saw strong demand for its cancer immunotherapy Keytruda. The drugmaker also narrowed its full-year profit outlook to reflect lower estimated tariff costs, among other factors. Sales of Keytruda topped $8 billion for the first time in a quarter, rising 10% from the […]
Read More